Latest IPOs
| Glaxo to double China R&D staff in few years |
|
SHANGHAI (Reuters) - GlaxoSmithKline, the world's second-largest drugmaker, plans to double its research and development staff in China to 350 people in the next few years, an executive said on Tuesday.
|
More
-
Police investigate alleged takeover leak to underworld
FEDERAL and state police are investigating whether sensitive information about a planned takeover bid involving two listed companies was leaked to an underworld identity, Mick Gatto, and his associates, amid increasing concerns about infiltration of the
-
PBN Releases Quarterly Review of Russian & CIS IPOs
All BusinessWire news Q1 2008 saw a marked decline in initial public offerings (IPOs) conducted by companies from Russia and other nations of the Commonwealth of Independent States (CIS) compared wi...